Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax Inc
(NQ:
NVAX
)
14.68
+2.36 (+19.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
59
60
Next >
Is Novavax a Buy After Its Vaccine Approval in Switzerland?
April 19, 2022
Novavax is late to the Covid-19 vaccine race and is up against some stiff competition. NVAX stock is in a tough spot.
Via
InvestorPlace
If You Invested $100 In Novavax 5 Years Ago, Here's How Much You Would Have Today
April 19, 2022
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 13.94% on an annualized basis producing an average annual return of 27.26%. Currently, Novavax has a market capitalization of...
Via
Benzinga
What's Going On With Novavax Stock Today?
April 19, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading lower Tuesday. The stock fell to new 52-week lows early in the session, but has since recovered. Novavax on Tuesday...
Via
Benzinga
UK-Based Start-Up Working On Next COVID-19 Vaccine Using Animal Feces: FT
April 19, 2022
Via
Benzinga
Japan's Health Ministry Panel OKs Approval Of Novavax's COVID-19 Vaccine: Report
April 18, 2022
Via
Benzinga
Novavax's COVID-19 Vaccine Approved In Switzerland
April 13, 2022
Via
Benzinga
Why Is Novavax (NVAX) Stock Down Today?
April 05, 2022
Today, investors in Novavax and NVAX stock appear to be spooked by some key rhetoric from Dr. Anthony Fauci regarding vaccinations.
Via
InvestorPlace
What Volatility in Novavax Means for Investors
April 18, 2022
Novavax continues to await FDA news about its Covid-19 vaccine, but that's not everything that drives the price of NVAX stock.
Via
InvestorPlace
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a...
Via
Benzinga
The Longer the Wait, The Smaller the Opportunity for Novavax
April 18, 2022
The delay in FDA approval is making the opportunity smaller for Novavax, but the opportunity still remains. NVAX stock is a hold.
Via
InvestorPlace
Novavax: The Party’s Over
April 15, 2022
Novavax was a great speculation on hopes for its Covid-19 vaccine, but now that the virus is becoming endemic, sentiment is waning.
Via
InvestorPlace
Will Novavax Stock Continue to Trend Lower?
April 14, 2022
NVAX stock is likely to remain depressed as the market for Covid-19 vaccine shrinks. Its combination vaccines could be a positive catalyst.
Via
InvestorPlace
Novavax And Its Plan To Target The Vaccine Resistant Notch Another Win
April 13, 2022
Swiss officials authorized the company's Covid vaccine for conditional use.
Via
Investor's Business Daily
Novavax Stock Up on Swiss Approval of Nuvaxovid
April 13, 2022
Novavax’s Covid-19 vaccine Nuvaxovid just got approved for in Switzerland. NVAX stock is up on news. It couldn’t have come at a better time.
Via
InvestorPlace
Novavax Stock Is Slumping: Why Buy the Dip?
April 12, 2022
Novavax lost nearly one-fifth of its value in the last week and risks further selling pressure, despite offering an mRNA alternative.
Via
InvestorPlace
Novavax Stock Is Tanking Despite New Covid-19 Vaccine Authorization
April 11, 2022
NVAX stock isn't a darling on Wall Street right now, but a rally could be just around the corner as Novavax pursues its global ambitions.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 07, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Vaccine Makers Down on FDA Meeting, Novavax Most at Risk
April 07, 2022
The major covid-19 vaccine makers are all down, anticipating bad-for-business news from the FDA. However, NVAX stock has the most to lose.
Via
InvestorPlace
Dear Biotech Investors: Novavax’s Comparable Vaccine Matters
April 07, 2022
Researchers compared Novavax’s vaccine to three others on the market, offering a thorough glimpse of protection from boosters.
Via
InvestorPlace
FDA Official Says Frequent COVID-19 Booster Shows Not Sustainable: WSJ
April 07, 2022
According to a U.S. health regulator, asking people to get COVID-19 boosters frequently wasn't sustainable because of vaccine fatigue, and authorities needed to develop a long-term strategy for...
Via
Benzinga
Is NVAX Stock a Buy at 52-Week Low? Skip the Novavax Portfolio Injection
April 06, 2022
NVAX stock could slide even further as research & development requirements stack up against its balance sheet's capacity.
Via
InvestorPlace
Novavax Just Hit A New Yearly Low, Here’s How To Buy It Even Lower
April 06, 2022
NVAX stock is still falling. Get paid for your patience to be a buyer at lower levels by selling expensive puts.
Via
InvestorPlace
Don’t Bet on New Highs for Novavax Stock
April 06, 2022
Investors would do well to avoid repeating the mistake of expecting moonshots in NVAX stock. The business may do better, but the stock won't.
Via
InvestorPlace
4 Top Stock Trades for Wednesday: Dogecoin, NVDA, TLRY, NVAX
April 05, 2022
Dogecoin, Nvidia, Tilray and Novavax were our top stock trades for Wednesday. Here's how the charts are setting up now.
Via
InvestorPlace
What's Going On With Novavax Shares Today?
April 05, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading significantly lower Tuesday. According to data from Benzinga Pro, Tuesday's trading volume is in line with Novavax's average trading volume over a 100-day...
Via
Benzinga
Novavax Has More Upside Ahead, as Covid-19 Shots Hit the Market
April 05, 2022
After Covid-19 vaccine delivery and regulatory woes, there is finally more upside than downside risks with NVAX stock.
Via
InvestorPlace
What to Make of Novavax’s Adolescent Covid-19 Vaccine Move
April 05, 2022
NVAX stock foray in the adolescent Covid-19 vaccine market could pay dividends but investors should tread with caution at this time.
Via
InvestorPlace
Novavax’s First Canadian Shipments Are Boosting NVAX Stock
April 04, 2022
Novavax delivered its first shipments to Canadian health authorities last week, and the news continues to help NVAX stock climb higher today.
Via
InvestorPlace
Novavax Stock Is Alluringly Attractive at This Stage
April 04, 2022
Novavax is close to securing FDA approval for its Covid-19 vaccine, yet NVAX stock is down since the end of January. What gives?
Via
InvestorPlace
10 Investor Questions About COVID-19, Answered
April 03, 2022
The COVID-19 outbreak has finally subsided in the U.S., but biotech investors still have plenty of lingering questions about the virus and what to expect in the months and years ahead. On Thursday,...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.